Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy] - 7-0x0-6, 7dihydro5Hphyrrolo [3, 4-b] pyrazine

Details for Australian Patent Application No. 2009349456 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Hsia, Richard; Misra, Tushar; Capila, Priya; Bai, Ge

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009349456

PCT Pub. Number WO2011/005250

Filing date 7 July 2009

Wipo publication date 13 January 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/005250 Priority application(s): WO2011/005250

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009349468-Systems and methods for modeling drillstring trajectories

2009349441-System for the decoration of cylindrical articles of fabriccoated neoprene rubber sheet